HALEON PLC-ADR
HLNNYSETrading Snapshot
- Day Range
- $8.98 – $9.08
- 52-Week Range
- $8.65 – $11.28
- Volume
- $2.69B
- Avg Volume
- $3.18B
- Shares Outstanding
- 4.40B
- Next Earnings
- Nov 15, 2026
Fundamentals Snapshot
- Annual Revenue
- $11.03B
- Last Q Revenue
- $5.64B
- P/E Ratio
- 18.8
- P/S Ratio
- 2.7x
- EPS (TTM)
- $0.36
- Dividend Yield
- 2.15%
- Dilution (1yr)
- −2.8%
Why Investors Own HLN
- ✓High-growth profile — revenue up +36.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 47% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HALEON PLC-ADR
HLN
StockOtter · stockotter.spaceAbout HALEON PLC-ADR
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
LCUT vs. HLN: Which Stock Is the Better Value Option?
Investors interested in stocks from the Consumer Products - Discretionary sector have probably already heard of Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best opti
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity of GLP-1 medication.
LCUT or HLN: Which Is the Better Value Stock Right Now?
Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Lifetime Brands (LCUT) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better
Haleon secures better shelf space at Walmart, Target in bid to boost market share
Sensodyne toothpaste maker Haleon has quietly negotiated better spots on shelves at U.S. retailers including Walmart and Target , to gain more visibility at a at a time when mounting grocery bills are hitting shopper sp
Comparing Haleon (NYSE:HLN) & Procter & Gamble (NYSE:PG)
Haleon (NYSE: HLN - Get Free Report) and Procter and Gamble (NYSE: PG - Get Free Report) are both large-cap consumer staples companies, but which is the better stock? We will contrast the two businesses based on the stre
Jefferies raises Haleon price target to 410p on margin strength
Jefferies has raised its price target for Haleon (Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health company behind Sensodyne and Advil, to 410p from 400p, maintaining its Buy rating. The broker highlighted a 70 basis p